Anzeige
Mehr »
Lynx Broker
Login
Dienstag, 22.10.2019 Börsentäglich über 12.000 News von 614 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1W7D4 ISIN: CA05156V1022 Ticker-Symbol: IKAP 
Tradegate
17.10.19
18:51 Uhr
4,220 Euro
-0,280
-6,22 %
Branche
Pharma
Aktienmarkt
NASDAQ Biotech
1-Jahres-Chart
AURINIA PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
AURINIA PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
4,340
4,420
21.10.
4,340
4,420
21.10.

Aktuelle News zur AURINIA PHARMACEUTICALS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoAurinia Pharmaceuticals: Comparative Analysis Reveals Voclosporin As A Drug With Mediocre Efficacy And Class-Typical Safety3
AURINIA PHARMACEUTICALS Aktien jetzt im kostenlosen Demokonto handeln!
MiWhy Aurinia Pharmaceuticals Is Soaring Today3
MiAurinia Pharmaceuticals Inc: Aurinia completes last patient visit in Aurora study5
MiAurinia Pharmaceuticals Inc. - 6-K, Report of foreign issuer1
02.10.Calcineurin Inhibitor For Lupus Nephritis? Pull Your Trigger Carefully On Aurinia Pharmaceuticals9
14.09.Aurinia Pharma inks $40M stock sales deal with Jefferies6
13.09.Aurinia Pharmaceuticals Inc. - 6-K, Report of foreign issuer1
13.09.Aurinia Pharmaceuticals Inc: Aurinia arranges $40M (U.S.) at-the-market offerings-
13.09.Aurinia Pharmaceuticals Inc. - S-8, Securities to be offered to employees in employee benefit plans-
11.09.Aurinia Pharmaceuticals (AUPH) Investor Presentation - Slideshow2
10.09.Why Aurinia Pharmaceuticals' Stock Is Up Big Today8
06.09.Aurinia Pharmaceuticals Inc: Aurinia CEO to present at H.C. Wainright conference-
09.08.Aurinia Pharmaceuticals (AUPH) Investor Presentation - Slideshow5
07.08.Aurinia Pharmaceuticals, Inc.'s (AUPH) CEO Peter Greenleaf on Q2 2019 Results - Earnings Call Transcript4
06.08.Aurinia Pharmaceuticals Inc: Aurinia loses $15.9-million (U.S.) in Q23
06.08.Aurinia Pharma EPS misses by $0.01, revenue in-line2
06.08.Aurinia Pharmaceuticals Inc. - 6-K, Report of foreign issuer-
01.08.Aurinia Pharmaceuticals Inc: Aurinia to release Q2 2019 results Aug. 62
18.07.Aurinia Pharmaceuticals Inc: Aurinia appoints Donley, Schulman as VPs3
18.07.Aurinia Pharmaceuticals Inc. - 6-K, Report of foreign issuer-
Seite:  Weiter >>
44 Nachrichten in den letzten 12 Monaten

Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1